Medical costs and quality-adjusted life years associated with smoking

A systematic review

Shari P. Feirman, Allison M. Glasser, Lyubov Teplitskaya, David R. Holtgrave, David Abrams, Raymond Niaura, Andrea C. Villanti

Research output: Contribution to journalReview article

Abstract

Background: Estimated medical costs ("T") and QALYs ("Q") associated with smoking are frequently used in cost-utility analyses of tobacco control interventions. The goal of this study was to understand how researchers have addressed the methodological challenges involved in estimating these parameters. Methods: Data were collected as part of a systematic review of tobacco modeling studies. We searched five electronic databases on July 1, 2013 with no date restrictions and synthesized studies qualitatively. Studies were eligible for the current analysis if they were U.S.-based, provided an estimate for Q, and used a societal perspective and lifetime analytic horizon to estimate T. We identified common methods and frequently cited sources used to obtain these estimates. Results: Across all 18 studies included in this review, 50 % cited a 1992 source to estimate the medical costs associated with smoking and 56 % cited a 1996 study to derive the estimate for QALYs saved by quitting or preventing smoking. Approaches for estimating T varied dramatically among the studies included in this review. T was valued as a positive number, negative number and $0; five studies did not include estimates for T in their analyses. The most commonly cited source for Q based its estimate on the Health Utilities Index (HUI). Several papers also cited sources that based their estimates for Q on the Quality of Well-Being Scale and the EuroQol five dimensions questionnaire (EQ-5D). Conclusions: Current estimates of the lifetime medical care costs and the QALYs associated with smoking are dated and do not reflect the latest evidence on the health effects of smoking, nor the current costs and benefits of smoking cessation and prevention. Given these limitations, we recommend that researchers conducting economic evaluations of tobacco control interventions perform extensive sensitivity analyses around these parameter estimates.

Original languageEnglish (US)
Article number646
JournalBMC Public Health
Volume16
Issue number1
DOIs
StatePublished - Jul 27 2016

Fingerprint

Quality-Adjusted Life Years
Smoking
Costs and Cost Analysis
Tobacco
Cost-Benefit Analysis
Research Personnel
Health
Smoking Cessation
Health Care Costs
Databases

Keywords

  • Medical costs
  • QALY
  • Smoking

ASJC Scopus subject areas

  • Public Health, Environmental and Occupational Health

Cite this

Medical costs and quality-adjusted life years associated with smoking : A systematic review. / Feirman, Shari P.; Glasser, Allison M.; Teplitskaya, Lyubov; Holtgrave, David R.; Abrams, David; Niaura, Raymond; Villanti, Andrea C.

In: BMC Public Health, Vol. 16, No. 1, 646, 27.07.2016.

Research output: Contribution to journalReview article

Feirman, Shari P. ; Glasser, Allison M. ; Teplitskaya, Lyubov ; Holtgrave, David R. ; Abrams, David ; Niaura, Raymond ; Villanti, Andrea C. / Medical costs and quality-adjusted life years associated with smoking : A systematic review. In: BMC Public Health. 2016 ; Vol. 16, No. 1.
@article{791d7fc79e3d4049b1a3c6348af8f867,
title = "Medical costs and quality-adjusted life years associated with smoking: A systematic review",
abstract = "Background: Estimated medical costs ({"}T{"}) and QALYs ({"}Q{"}) associated with smoking are frequently used in cost-utility analyses of tobacco control interventions. The goal of this study was to understand how researchers have addressed the methodological challenges involved in estimating these parameters. Methods: Data were collected as part of a systematic review of tobacco modeling studies. We searched five electronic databases on July 1, 2013 with no date restrictions and synthesized studies qualitatively. Studies were eligible for the current analysis if they were U.S.-based, provided an estimate for Q, and used a societal perspective and lifetime analytic horizon to estimate T. We identified common methods and frequently cited sources used to obtain these estimates. Results: Across all 18 studies included in this review, 50 {\%} cited a 1992 source to estimate the medical costs associated with smoking and 56 {\%} cited a 1996 study to derive the estimate for QALYs saved by quitting or preventing smoking. Approaches for estimating T varied dramatically among the studies included in this review. T was valued as a positive number, negative number and $0; five studies did not include estimates for T in their analyses. The most commonly cited source for Q based its estimate on the Health Utilities Index (HUI). Several papers also cited sources that based their estimates for Q on the Quality of Well-Being Scale and the EuroQol five dimensions questionnaire (EQ-5D). Conclusions: Current estimates of the lifetime medical care costs and the QALYs associated with smoking are dated and do not reflect the latest evidence on the health effects of smoking, nor the current costs and benefits of smoking cessation and prevention. Given these limitations, we recommend that researchers conducting economic evaluations of tobacco control interventions perform extensive sensitivity analyses around these parameter estimates.",
keywords = "Medical costs, QALY, Smoking",
author = "Feirman, {Shari P.} and Glasser, {Allison M.} and Lyubov Teplitskaya and Holtgrave, {David R.} and David Abrams and Raymond Niaura and Villanti, {Andrea C.}",
year = "2016",
month = "7",
day = "27",
doi = "10.1186/s12889-016-3319-z",
language = "English (US)",
volume = "16",
journal = "BMC Public Health",
issn = "1471-2458",
publisher = "BioMed Central",
number = "1",

}

TY - JOUR

T1 - Medical costs and quality-adjusted life years associated with smoking

T2 - A systematic review

AU - Feirman, Shari P.

AU - Glasser, Allison M.

AU - Teplitskaya, Lyubov

AU - Holtgrave, David R.

AU - Abrams, David

AU - Niaura, Raymond

AU - Villanti, Andrea C.

PY - 2016/7/27

Y1 - 2016/7/27

N2 - Background: Estimated medical costs ("T") and QALYs ("Q") associated with smoking are frequently used in cost-utility analyses of tobacco control interventions. The goal of this study was to understand how researchers have addressed the methodological challenges involved in estimating these parameters. Methods: Data were collected as part of a systematic review of tobacco modeling studies. We searched five electronic databases on July 1, 2013 with no date restrictions and synthesized studies qualitatively. Studies were eligible for the current analysis if they were U.S.-based, provided an estimate for Q, and used a societal perspective and lifetime analytic horizon to estimate T. We identified common methods and frequently cited sources used to obtain these estimates. Results: Across all 18 studies included in this review, 50 % cited a 1992 source to estimate the medical costs associated with smoking and 56 % cited a 1996 study to derive the estimate for QALYs saved by quitting or preventing smoking. Approaches for estimating T varied dramatically among the studies included in this review. T was valued as a positive number, negative number and $0; five studies did not include estimates for T in their analyses. The most commonly cited source for Q based its estimate on the Health Utilities Index (HUI). Several papers also cited sources that based their estimates for Q on the Quality of Well-Being Scale and the EuroQol five dimensions questionnaire (EQ-5D). Conclusions: Current estimates of the lifetime medical care costs and the QALYs associated with smoking are dated and do not reflect the latest evidence on the health effects of smoking, nor the current costs and benefits of smoking cessation and prevention. Given these limitations, we recommend that researchers conducting economic evaluations of tobacco control interventions perform extensive sensitivity analyses around these parameter estimates.

AB - Background: Estimated medical costs ("T") and QALYs ("Q") associated with smoking are frequently used in cost-utility analyses of tobacco control interventions. The goal of this study was to understand how researchers have addressed the methodological challenges involved in estimating these parameters. Methods: Data were collected as part of a systematic review of tobacco modeling studies. We searched five electronic databases on July 1, 2013 with no date restrictions and synthesized studies qualitatively. Studies were eligible for the current analysis if they were U.S.-based, provided an estimate for Q, and used a societal perspective and lifetime analytic horizon to estimate T. We identified common methods and frequently cited sources used to obtain these estimates. Results: Across all 18 studies included in this review, 50 % cited a 1992 source to estimate the medical costs associated with smoking and 56 % cited a 1996 study to derive the estimate for QALYs saved by quitting or preventing smoking. Approaches for estimating T varied dramatically among the studies included in this review. T was valued as a positive number, negative number and $0; five studies did not include estimates for T in their analyses. The most commonly cited source for Q based its estimate on the Health Utilities Index (HUI). Several papers also cited sources that based their estimates for Q on the Quality of Well-Being Scale and the EuroQol five dimensions questionnaire (EQ-5D). Conclusions: Current estimates of the lifetime medical care costs and the QALYs associated with smoking are dated and do not reflect the latest evidence on the health effects of smoking, nor the current costs and benefits of smoking cessation and prevention. Given these limitations, we recommend that researchers conducting economic evaluations of tobacco control interventions perform extensive sensitivity analyses around these parameter estimates.

KW - Medical costs

KW - QALY

KW - Smoking

UR - http://www.scopus.com/inward/record.url?scp=84979586957&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84979586957&partnerID=8YFLogxK

U2 - 10.1186/s12889-016-3319-z

DO - 10.1186/s12889-016-3319-z

M3 - Review article

VL - 16

JO - BMC Public Health

JF - BMC Public Health

SN - 1471-2458

IS - 1

M1 - 646

ER -